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1 
INTRODUCTION 
 
Keratomycosis is extremely common in tropics and is an important  
 
cause of corneal morbidity. Fungi are opportunistic agents infecting the  
 
cornea.Seldom they infect healthy cornea; Most often there exists some 
predisposing factor which help colonization of fungi.[Forster,R.K 
Rebell,G.The diagnosis and management of  keratomycoses. 
Arch.ophthalmol.93:975,1975]. 
 
 
Fungal infections of the cornea remain a therapeutic challenge to  
 
ophthalmologists even today due to interplay of various factors like  
 
delayed presentation, chronicity of the infection, resistance to antifungal  
 
agents, resemblance to other forms of stromal keratitis and superadded  
 
bacterial infections. More than 68 species of fungi are known to cause  
 
keratomycosis globally.  
 
Early recognition and treatment is crucial in containing the disease  
 
which is why, various newer modalities of treatment are being  
 
constantly worked.  
 
In our study, we worked on 100 cases of fungal keratitis and have  
established topical 10% Sodium chloride as a useful adjunct in the  
 
management of keratomycosis. 
                                                 
                                                                                                          
  
2 
EPIDEMIOLOGY 
 
 
Fungal spores are ubiquitous, produced in large numbers and are  
 
highly resistant. They germinate and subsist on organic substrates.  
 
 
Fungi causing keratomycosis by and large belong to moniliaceae, 
 
Dematiaceae and yeast like Candida. 
 
Moniliaceae include light coloured fungi like Fusarium and Aspergillus  
 
Species while Dematiaceae include dark coloured fungi like Alternaria  
 
and Curvularia. 
 
 
In South India, Aspergillus is the common causative fungus (36%) in  
 
keratomycosis followed by Penicillium species (29%). Fusarium  
 
keratomycosis is not as common as reported in the literature. In  
 
endophthalmitis there is a preponderance of Penicillium as the  
 
causative fungus. 
 
 
 
Mycotic endophthalmitis is seen following cataract surgery in 64%  
 
of cases.  
 
  
                                                                                                                       
                                                                                                                         
  
3 
 
Contrary to expectations, onset of endophthalmitis often occurs within 2  
 
weeks of surgery in most cases.  
 
 
Trauma with organic matter is an important predisposing factor in  
 
keratomycosis. These observations are discussed in relation to the  
 
clinical features. 
 
[R.Srinivasan, Kanungo.R, Goyal J.L, Spectrum of oculomycosis in  
 
south India. Acta. ophthalmol 1991;] 
 
Candida and Aspergillus are more common in cooler climates. 
 
 
 
FUSARIUM: 
 
F u s a r i u m  s p e c i e s  a r e  s a p r o p h y t i c  f u n g i  w h i c h  g r o w  o n  
 
decaying vegetation and on wild and cultivated plants. Agricultural  
 
labourers are predisposed to infections by this organism. F.solani is the  
 
most common culprit. 
 
 
 
CANDIDA: 
 
Keratomycosis due to Yeast is most commonly due to C.albicans.  
 
C.parapsilosis is a rare isolate. 
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ASPERGILLUS: 
 
 
Aspergillus thrives on corn, soil and decaying vegetation.  
 
Hospital air has abundant spores.  
 
Aspergillus has been isolated from both tropical and temperate zones.    
 
A.fumigatus is the most common isolate although A.flavus and  
 
A.niger has also been reported. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                              
                                     
 
 
                                                                                             
                                                                                              
  
5 
 
GENERAL MYCOLOGY 
 
 
Fungi are eukaryotic protists that differ from bacteria and other  
 
prokaryotes.They have rigid cell walls containing chitin, mannan and  
 
other polysaccharides.Cytoplasmic membrane contains sterols. 
 
 
They possess true nuclei with nuclear membrane and paired  
 
chromosomes.  
 
They divide sexually, asexually or either way. They may be unicellular  
 
or bicellular. 
 
 
Hypha is a thread like, tubular structure produced by cell elongation. 
 
Mycelia are a tangled mass of hyphae. Moulds or filamentous fungi  
 
form mycelia. 
 
 
Mycelia can be vegetative mycelia which grows into the media or aerial  
 
mycelia which projects from the surface. 
       
  
                  
6                     
MORPHOLOGY 
 
 
FUSARIUM:  
 
They have characteristic microconidia and 
 
macroconidia.The main identifying feature is the large banana shaped  
 
macroconidia that are produced on short lateral hyphae. Fusarium  
 
produces macroconidia on sporodochia. This sporodochial type mutates  
 
forming a mycelial type, with abundant aerial mycelia and a pionnotal  
 
type, which produces lots of conidiophores  in sheets across the culture. 
 
Macroconidia are septate with apical and basal cells. 
 
 
 
ASPERGILLUS: 
 
Aspergillus is easy to identify morphologically by the Conidiophore with  
 
its swollen end surrounded by flask shaped sterigmata, each of which  
 
produces long chains of coccoid conidia that radiate from the terminal  
 
end. Hyphae are septate and branch dichotomously . 
 
 
Rapidly progressing infections have regular hyphae while indolent  
 
lesions have irregular hyphae. 
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DEMATIACIOUS FUNGI: 
 
These fungi produce brown pigmentation of colonies and are  
 
saprophytic. 
 
 
 
CANDIDA: 
 
They are ovoid or spherical budding yeasts; Base of the bud is narrow,  
 
and the bud is slightly off axis. They lack symmetry.  Both true and  
 
pseudo hyphae are seen of which the mycelial form is the invasive form.  
 
 
Presence of hyphal elements in addition to yeast forms in Gram stained  
 
specimens is indicative of tissue colonization. Candida albicans  
 
produces characteristic chlamydospores.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                       
  
8 
CLASSIFICATION OF FUNGI 
 
  
                                                      1.Moulds  
                                                                                                                 
 
 
                    Septate                                                                   Non-septate                           
               
                                                                   
Pigmented                  Non-pigmented     Rhizopus                           
                                                                                                      Absida  
Alternaria                      Aspergillus                                              Mucor                     
Curvularia                     Acremonium                                                               
Cladosporium               Cylindrocarpon 
Drechslera                     Fusarium 
Melanconiales               Myrathecum         
Sphaeropsidales            Allescheria boydii 
                                      Penicillium  
                                      Volutella                        
  
                                       
 
 
                                         2. Dimorphic Fungi                                                      
                              
                                  Blastomyces                                                                       
                                                    Sporothrix 
                                                    Coccidioides  
                                                    Histoplasma 
                                                      
                                    
                                                    3. Yeasts 
 
                              Candida  
                              Cryptococcus 
                              Rhodotorulae  
 
                         
  
9 
CULTURAL CHARACTERISTICS 
 
               
Sabouraud’s dextrose agar without cycloheximide and Brain Heart  
 
Infusion broth with chloramphenicol are the preferred media for  
 
isolation of corneal pathogens. 
 
 
Media should be incubated for a minimum of two weeks and ideally one  
 
month. Fungal isolation is usually performed at room temperature [25  
 
degrees Celsius ]. One set of culture media is incubated at 37 degrees  
 
Celsius for thermophylic fungi. Agar plates are placed in a plastic bag  
 
containing moisture pack to enhance its life. 
 
 
Majority of fungi causing keratitis can be identified in culture within 3  
 
days. Aspergillus and Fusarium colonies appear within 48 hours in  
 
blood agar, Sabouraud’s dextrose agar and Brain Heart Infusion agar.  
 
However appreciable colonies appear only after 1-2 weeks. Media  
 
should be observed for at least 2 weeks before they are considered  
 
negative.  
 
Growth rate,colony characteristics, pigmentation,microscopic appearance  
 
are considered for species identification. 
 
 
 
 
                                                                                                                       
  
10 
PATHOGENESIS 
 
Fungal keratitis is more prevalent in warmer climates.In south India  
 
prevalence is more in September and October during harvest. 
 
Any persistent epithelial defect, prolonged topical steroids, trivial  
 
injuries, Herpes simplex infection, contact lens wear, predispose eyes to  
 
fungal infection.  
 
Most of the keratomycosis is due to saprophytic fungi present in lids  
 
and conjunctiva, like candida, Aspergillus,Penicillium, Rhodotorula,  
 
Cladosporium and Alternaria.  
 
 
Damage to cornea is often secondary to, 
 
              a) Disruption of corneal lamellae by direct invasion of fungal  
 
hyphae, 
 
              b) Inflammatory response elicited by the attendant T-cells, 
  
polymorphonuclear leucocytes and     
               
              c)Tissue destruction caused by fungal toxins.  
 
 
Fungal keratitis often resembles other forms of stromal keratitis and  
 
escapes clinical attention for quite long time before presentation. 
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Incubation period varies from 2 days to 2 weeks allowing extensive  
 
invasion by fungal filaments. 
 
Histopathological examination often reveals presence of mycelia parallel  
 
to corneal lamellae . 
 
Perpendicular orientation of hyphae indicates virulent fungi.  
 
[Naumann,Green,Zimmerman et.al A Histopathological study of 73  
 
cases of mycobial keratitis American journal of ophthalmology 1967]. 
 
 
Candida albicans, especially the yeast forms with surface mannoprotein  
 
adhesions can cause keratomycosis. 
 
Increased virulence is often attributed to the ability to form hyphae. 
 
This is due to the greater potential of these hyphal forms to get attached  
 
to corneal surface. 
 
 
Also mannoproteins found on hyphal and pseudo hyphal forms inhibit  
 
neutrophil chemotaxis and subsequent phagocytosis by these cells.  
 
[Nelson R.D et.al,candida mannan;chemistry,suppression of cell  
 
mediated immunity & possible mechanisms of action ;clinical  
 
microbiological review, 1991]. Leucocyte infiltration of cornea adds to  
 
further insult in fungal keratitis.  
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Ring abscesses demonstrate neutrophils, while plasma cells and  
 
occasional eosinophils around fungal filaments are not uncommon. 
 
Size of fungal filaments pose a problem for neutrophil phagocytosis.But  
 
still neutrophils exert their fungicidal effect by release of lysosomal  
 
enzymes and oxygen metabolites.Associated tissue destruction is almost  
 
inevitable. Fungi produce cytotoxins and toxic enzymes. 
 
Cytotoxins include, 
 
Aflatoxins and ochrotoxins [Aspergillus] 
 
Trichothenes [Fusarium and Acremonium] 
 
Gliotoxins [Aspergillus,penicillium and Gliocladium]. 
 
Toxic enzymes include, 
 
Proteases  
 
Pseudo collagenases & 
 
Phospho lipidases. 
 
 
Trichothenes are cytotoxic and cytostatic i.e. they exhibit severe  
 
inflammatory response at lower concentrations and tissue necrosis at  
 
higher concentrations. 
 
Gliotoxins have antibacterial, antiviral and antiphagocytic properties. 
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Fusarium produces several mycotoxins and destructive enzymes which  
 
cause inflammation and tissue damage. It is capable of multiplying at 37  
 
degrees without much inflammation. Posterior chamber and lens are  
 
frequently involved causing fungal granuloma. 
 
 
Fungi can penetrate Descemet’s membrane with relative ease. Unlike  
 
Bacteria, fungal hyphae can be well demonstrated from anterior  
 
chamber. 
 
 
Hyphal and pseudohyphal mannoproteins inhibit attachment and  
 
digestion by neutrophils. Hyphal forms are capable of invading  
 
epithelial cells and leucocytes. 
 
 
Some fungi produce proteases and lipases which help host invasion and  
 
surface proteins for epithelial adherence. 
 
 
                 
                      
 
 
 
 
 
 
 
                        
  
14 
IMMUNE RESPONSE 
 
 
Once fungal filaments gain entry into cornea, cell mediated immunity  
 
comes into play. Polymorphonuclear neutrophils first attach themselves  
 
to  hyphae  th rough  complement  independen t  mechan i sms . 
 
They produce myeloperoxidases and hydrogen peroxide which help in  
 
destruction of fungal elements.[Diamond ,Krzesicki & Wellington;  
 
Damage to pseudohyphal forms of C.albicans by neutrophils in the  
 
absence of serum. J.clin.invest.61:349;1978] 
 
 
Monocytes and T-cells also exhibit such fungicidal activity. 
 
Patients with keratomycosis also demonstrate a fall in Ig M and a raise  
 
in Ig G. [serum immunoglobulins in mycotic keratitis--an interim  
 
report. Srinivasan et.al. Indian Journal of ophthalmology 1987]. 
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HISTOPATHOLOGY 
                                                       
                                             
Involved cornea exhibits necrosis of lamella and acute inflammatory  
 
reaction. Antigenic response to fungal antigen results in the formation  
 
of immune ring. Severe uveitis and anterior chamber reaction occur. 
 
 
Multiple microabscesses surrounding the main lesion form satellite  
 
lesions with intervening clear cornea in between. 
 
There is severe limbal infiltration with lymphocytes and plasma cells  
 
with progressive keratitis resulting in a ring abscess. 
 
 
With time hyphae can penetrate stromal lamellae and Descemet’s,  
 
spreading into the anterior chamber forming retro corneal or anterior  
 
chamber inflammatory mass. 
 
 
 
 
 
 
 
 
 
                
 
 
 
                               
  
16 
CLINICAL FEATURES 
  
                                                        
Patients usually present with a history of some form of trivial injury,  
 
often with vegetative matter. 
 
Symptoms include photophobia, watering, redness, diminution of vision  
 
and dull pain. 
                                         
Virulent fungal infections can occur in apparently normal cornea with  
 
no demonstrable deficiency in host resistance.   
 
 
Less virulent organisms like candida are more common in compromised  
 
hosts like Sjogren’s syndrome, erythema multiforme, endocrinopathy,  
 
immunodeficiency, alcoholism, diabetes or hypovitaminosis A. 
 
 
Predisposing factors: 
 
           These include, 
 
                                   Lid abnormalities like, ectropion, entropion,                                   
                                     
                                   trichiasis,               
                                 
                                   Stye & Molluscum 
                                   
                                   Chronic dacryocystitis 
  
                                   Any persistent epithelial defect 
 
                                   Stromal ulceration   
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                                   Herpes simplex infection 
  
                                   Topical steroid use 
 
                                   Contact lens wear. 
                                                                                                                                        
 
Saprophytic fungi contribute to a significant number of corneal ulcers. 
 
 
Upto 7% of normal eyes harbour Saprophytic fungi in lids and  
 
conjunctiva as transient inhabitants. 
 
                                
 
                                 Most common species are, 
 
                                        Candida 
 
                                        Pencillium  
 
                                        Rhodotorula 
 
                                        Cladosporium & 
 
                                        Alternaria  
 
 
These Saprophytic fungi become pathogenic whenever the host is  
 
predisposed.  
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Clinical features of keratitis caused by moulds: 
 
 
 
Occurs more frequently in young individuals who are actively engaged  
 
in outdoor activities. Signs may be delayed for 24-48 hours after the  
 
injury.  
 
There is no predisposing factor. Inflammation shows grayish white  
 
infiltration with rough textured surface areas raised above uninvolved  
 
cornea. Epithelial defect may or may not be present. 
 
 
Stromal abscess with intact overlying epithelium is not an uncommon  
 
finding. Edges are feathery and characteristic satellite lesions are  
 
present. 
 
Hypopyon and endothelial plaque are quite common.Antibody reaction  
 
to the fungal antigen results in a ring infiltrate –the immune ring. 
 
 
Circumcorneal congestion and severe anterior chamber reaction do  
 
occur. Hypopyon is fixed which does not change position with head  
 
movements. This is due to anterior chamber invasion by fungal hyphae  
 
as well as fibrinous nature of the exudates. Another characteristic  
 
feature of fungal hypopyon is its waxing and waning nature.   
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Clinical features of keratitis caused by yeasts: 
 
 
In general the host is compromised. Prior steroid treatment or a  
 
predisposed cornea carries a high risk. 
 
Inflammation is more focal and suppurative resembling bacterial  
 
keratitis. Lesions are oval, plaque like elevated and widely surrounded  
 
by stromal oedema. 
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DIAGNOSTIC PROCEDURES 
 
                                            
Initial procedure is collection of swabs from conjunctival sacs and lid  
 
margins using cotton swabs dipped in Brain Heart infusion broth or  
 
Trypticase Broth. These are inoculated separately on Blood agar,  
 
Thioglycollate Broth and Sabouraud’s Dextrose agar. 
 
                                                   
Corneal scrapings are obtained with Kimura platinum spatula or B.P  
 
blade 15, after applying 0.5% proparacaine using slit lamp. ‘C’ shaped  
 
inoculations are made on the surface of culture media. 
 
 
 
10% Potassium hydroxide mount: 
 
For KOH mount, smear is transferred to a pre cleaned slide marked  
 
with wax pencil on the reverse.  
 
Two drops of 10% KOH with 0.1% glycerol is placed over the smear  
 
and covered with a cover slip. 
 
KOH dissolves cells and debris and fungal elements are highlighted. 
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Gram’s and Giemsa stain: 
 
Gram’s stain selectively stains fungal protoplasm without staining the  
 
cell wall. Invariably fungi show a gram positive reactivity. 
 
In Giemsa stain fungal filaments appear purple-blue. 
 
 
 
Gracott Gomori methenamine silver staining: 
                                                       
Gomori methenamine silver stain stains cell walls and septa black which  
 
are easily recognized against the light green background. Principle is  
 
reduction of silver by the oxidized carbohydrate components of the  
 
fungal cell wall which stains it black. 
 
Forester et al,described a technique by which smears stained previously  
 
by Gram’s or Giemsa can be stained with this method. 
 
 
 
PAS reagent: 
 
PAS can demonstrate fungi in tissues and cytologic preparations. PAS  
 
hydrolyses and oxidizes cell wall polysaccharides and stains hyphae  
 
bright red. 
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Lactophenol cotton blue: 
  
Lactophenol cotton blue stain clearly demonstrates fungal elements  
 
from cultures. 
 
 
Calcofluor stain: 
 
For laboratory diagnosis of mycotic keratitis, demonstration of fungal  
 
pathogens on direct microscopy and their isolation by culture is  
 
essential. The addition of Calcofluor white stain to the diagnostic  
 
armamentarium has significantly increased the sensitivity of smear  
 
examination on direct microscopy. 
 
 
Acridine orange technique: 
 
It causes a brilliant orange yellow fluorescence of fungal elements under  
 
a fluorescent microscope. 
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RECENT TECHNIQUES IN DIAGNOSIS 
 
                                                
 
Fungal filaments from corneal scrapings can be stained with fluorescein  
 
conjugated concanavalin A. Non fluorescent stains like calcofluor white,  
 
blankophor, uvitex 2B are used with increasing success in identifying  
 
mycotic infections. 
 
Tagged antibodies in immunoassays are also useful for picking up  
 
fungal filaments.Enzyme immunoassays and immunofluorescence are  
 
highly sensitive and specific diagnostic tools. 
 
 
Use of PCR targeting of internal transcribed spacer regions and single- 
 
stranded conformation polymorphism analysis of sequence variation in  
 
different regions of rRNA genes in fungi for rapid diagnosis of mycotic  
 
keratitis is coming up. 
 
 
The increased incidence of fungal infections in the recent past has been  
 
attributed to the increase in the number of human immunodeficiency  
 
virus-positive and AIDS patients. Early diagnosis of mycoses in patients  
 
is crucial for prompt antifungal therapy.  
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Immunological methods of diagnosis have not been found to be  
 
satisfactory, and recent research has been diverted to the use of PCR for  
 
the sensitive and early diagnosis at the molecular level. Different regions  
 
of the rRNA gene are targeted to diagnose cases of mycotic keratitis and  
 
identify the causal agents. 
 
 
Six fungus-specific primers (primers ITS1, ITS2, ITS3, ITS4, invSR1R,  
 
and LR12R) are used, and the amplified products are analyzed by  
 
single-stranded conformation polymorphism (SSCP) analysis.  
 
Dendrograms of these SSCP patterns, prepared on the basis of  
 
Jaccard's coefficient, indicate that the PCR products obtained with  
 
primer pair ITS1 and ITS2 are the best for the identification of fungi. 
 
 
These results are confirmed by sequencing of the PCR products, and the  
 
approach has been successfully tested experimentally for the detection  
 
of mycotic keratitis caused by Aspergillus fumigatus and is used for the  
 
diagnosis of fungal corneal ulcers in patients. 
 
[Kumar M, Shukla PK.et.al.J Clin Microbiol. 2005 Feb;43(2):662-8.] 
 
Corneal topography is also used extensively now a days to assess the  
 
change in  corneal  curvature once the kerat i t is  has healed . 
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MANAGEMENT OF KERATOMYCOSIS 
 
HISTORY: 
                                         
Before 1969 most cases were treated with topical Amphotericin B with  
 
which toxicity was a major issue. 
 
During the 1970’s the related polyene Natamycin was used  
 
investigationally and became the treatment of choice for fungal  
 
keratitis.[Forster,R.K & rebel.G,The diagnosis and management of  
 
keratomycosis, Medical & surgical management. Arch.ophthal. 93.  
 
1134,1975] 
 
 
Since then so many molecules have evolved and stood the test of time  
 
like, imidazoles, triazoles and pyrimidines. 
 
In 1979 Natamycin got FDA approval and the commercial version was  
 
put in market by Alcon as a 5% suspension. 
 
In 1986 O’Day and associates established that the corneal uptake and  
 
penetration of C-labeled 5% Natamycin  was better than 0.15%  
 
amphotericin B in corneas with intact epithelium. 
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Hofling & Forster worked on the comparative study of  corneal  
 
penetration of six antimycotics in a in- vitro perfusion chamber using  
 
human eye. 
 
It was found that flucytosine penetrates the best, followed by polyenes  
 
and azoles. 
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Pharmacotherapy of fungal eye infections: 
 
Fungal eye infections are rare. Trauma associated with contamination  
 
by vegetative material, contact lens wear and long term corticosteroid  
 
use are common risk factors.  
 
The aims of treatment are to preserve visual function, which depends on  
 
the rapid diagnosis and efficient administration of appropriate  
 
antifungal therapy. 
 
This necessitates a clinical suspicion of fungal aetiology and taking  
 
appropriate smears and cultures as early as possible to identify the  
 
fungal organism. Currently there are three main classes of drugs  
 
available for use in fungal eye infections: Polyenes, Azoles as derivatives  
 
of imidazoles, and 5-Fluorocytosine.  
 
 
Of the polyenes, amphotericin B, natamycin and nystatin are of clinical  
 
ophthalmic use. Based on better pharmacokinetic profiles and spectra  
 
of antifungal activity, the triazoles are the agents of choice.  
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Successful treatment of fungal keratitis depends on early initiation of  
 
specific therapy consisting of topically-applied antifungal agents since  
 
topical administration is most likely to provide the best opportunity for  
 
achieving therapeutic corneal levels.  
 
 
Hence, the molecular weight of the various antifungal agents is of  
 
importance since it influences their ability to penetrate the corneal  
 
epithelium.  
 
 
Systemic administration may be necessary for resistant fungal ulcers.  
 
for fungal endophthalmitis, to preserve visual function and eliminate  
 
the fungal pathogen, topical, systemic and possibly intraocular  
 
antifungal therapy is used, although some do not recommend use of  
 
systemic agents for exogenous endophthalmitis. 
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Mechanism of action of antifungals: 
 
                                              
Large polyenes approximate the length of membrane phospholipids and  
 
form circular channels for the free passage of  potassium chloride and  
 
other ions, which leads to electrolyte imbalance and eventual cell death. 
 
 
Smaller polyenes accumulate on the membrane forming blisters that  
 
disrupt and cause the sterol phospholipids film to break down. 
 
 
Azoles exert their antifungal effect by interference with cell membrane  
 
ergosterol synthesis, and by directly acting on the fungal cell membrane  
 
making them leaky. 
 
 
In vitro MICs demonstrate that polyenes are drugs of choice for  
 
filamentous fungi and yeasts. 
 
Triazoles are effective in treatment of Candida albicans keratitis and  
 
are as effective as amphotericin B and less toxic.  
 
[Brooks,J.G, et al. Comparative topical triazole therapy of experimental  
 
C.albicans kertitis.Invest.oph.1990].                     
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Azoles though useful in selective occasions like paecilomyces species,  
 
have little penetrating ability and are reserved for superficial keratitis. 
 
 
Fluconazole is promising because of its penetration and distribution in  
 
ocular tissues after oral administration. 
 
 
Mode of delivery: 
                               
Apart from topical drops, topical delivery of antifungals by  
 
iontophoresis and  delivery by collagen shields are being developed  
 
which increases convenience and compliance.  
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 Minimal Inhibitory Concentration for common fungi: 
 
 
Organism  Amphotericin 
B 
Natamycin Miconazole Ketoconazole Flucytosine 
Fusarium 1.25 2.5 12.5 25.0 >100 
Aspergillus 2.5 5.0 1.6 6.25 >100 
Paecilomyces 5.0 >10.0 1.6 1.6 >100 
Curvularia 0.32 1.25 3.13 3.13 >100 
Candida 5.0 5.0 3.13 3.13 0.39 
 
 
 
 
In vitro susceptibility tests of ocular fungal isolates to antimycotics is  
 
used to rationalize treatment once organism is identified. 
 
 
Studies also demonstrate that polyenes are the antimycotics of choice  
 
for filamentous fungi. 
 
 
Topical corticosteroids affect all antifungals except Amphotericin B in a  
 
concentration of 0.15-0.50% .[O’Day D.M et al.Efficacy of antifungals  
 
in cornea & influence of corticosteroids Invest.ophthal. Vis.Sci. 25:331,  
 
1984]. 
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CLASSIFICATION OF ANTIFUNGALS 
 
                                    1.Polyenes                                           
                                                                        
        Large                                                           small                                         
 
Amphotericin B                                                          Natamycin                                
Nystatin                                                                         
                                                                          
                                                                              
                                                   
                                      2.Azoles                                                
  
 Imidazoles                                                   Triazoles                          
 
Miconazole                                                              Fluconazole        
Econazole                                                                Itraconazole 
Ketaconazole                                                          Terconazole 
Clotrimazole                                                           Saperconazole 
Thiabendazole  
 
 
                                      3.Pyrimidines 
  
                                           Flucytosine  
 
                              
                                4.Miscellaneous 
 
                                      Endomycin 
                                           Hamycin 
                                           Trichomycin 
                                           Dermostatin 
                                           Lucimycin 
                                           Candicidin 
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AMPHOTERICIN B: 
 
Amphotericin B is a heptaene polyene and is fungistatic,insoluble and  
 
toxic due to sterol binding in human cell membranes. 
 
Mechanism of action: 
 
Binds to ergosterol in cell membranes forming trans membrane  
 
channels leading onto electrolyte loss and cell death. 
 
Spectrum of activity: 
 
Active against candida,Aspergillus,Cryptococcus and Fusarium. 
 
Adverse effects: 
 
Topical : Burning, chemosis, epithelial clouding, greenish discoloration  
 
and punctuate keratopathy. Most of these are secondary to the bile salts  
 
used in drops to stabilize the solution. 
 
Systemic toxicity : This is due to membrane damage to RBCs and renal  
 
tubular cells. 
 
Limitations: 
 
Toxicity, insoluble and fungistatic,cannot penetrate intact epithelium  
 
and unstable compound. 
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Dosage :                         
 
Topical application of 0.05-0.15% eye drops every 5 minutes for 1 hour  
 
followed by hourly application. Amphotericin B should be prepared in  
 
distilled water. 
 
Collagen shields soaked in Amphotericin B are as effective as eye drops. 
 
Subconjunctival injections are contraindicated for fear of local necrosis. 
 
 
 
NATAMYCIN: 
 
This is a tetraene polyene antifungal and is the only antifungal available  
 
for commercial use. 
 
Mechanism of action: 
 
It accumulates by binding to sterols in cell membranes and disrupts  
 
their integrity. 
 
Spectrum of activity: 
 
Highly effective against filamentous fungi like Fusarium, Aspergillus,  
 
curvularia  and Cladosporium. 
 
Also active against yeast especially Candida albicans and Torulopsis.  
 
[For s t e r ,R .K Rebe l l ,G .The  d iagnos i s  and  management  o f  
 
keratomycosis. Arch.ophthalmol.1975]. 
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Dosage: 
 
5% suspension is applied every 30 minutes for the first 3-4 days, then  
 
six to eight times daily. 
 
Adverse effects: 
 
Epithelial toxicity and conjunctival granuloma. 
 
NYSTATIN: 
 
Nystatin too is a polyene antibiotic. A solution prepared in a  
 
concentration of 50,000-1,00,000 IU/ml can be used in the treatment of  
 
superficial Candida keratitis. Usually it is administered every 2 hours. 
 
 
IMIDAZOLES: 
 
Mechanism of action: 
 
Imidazoles inhibit ergosterol synthesis which is an important  
 
constituent of fungal cell membrane. At higher concentrations it directly  
 
causes cell wall damage. i.e. they are fungistatic at lower concentrations  
 
and fungicidal at higher concentrations in vitro.  
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MICONAZOLE: 
 
Spectrum of activity: 
 
Active against Aspergillus, Paecilomyces, Curvularia, Cladosporium  
 
and Penicillium. 
 
Routes of administration: 
 
Topical,subconjunctival and systemic. 
 
Dosage :             
 
Topical:              1% solution hourly 
                     
Subconjunctival: 5-10 mg 
                      
Systemic:            30mg/kg/day intravenously   
 
Adverse effects: 
 
Superficial punctuate keratitis 
 
CLOTRIMAZOLE: 
 
Spectrum of activity: 
 
Highly active against Aspergillus,candida and Torulopsis.Most valuable  
 
in the treatment of keratitis caused by  Aspergillus species. 
 
 
Dosage:                
 
Topical: 1% drops hourly. 
 
Subconjunctival: 5-10 mg 
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KETACONAZOLE: 
 
It is more water soluble and better absorbed after oral administration  
 
Spectrum of activity:  
 
Paecilomyces, Curvularia,  candida and Fusarium. 
 
Topical penetration is good and preparations are well tolerated.  
 
 
Dosage: 
 
Topical:        1%-2% hourly 
 
Systemic:      200-400 mg/day in a single dose. 
 
Terfendine and astemizole are contraindicated in patients taking    
 
ketaconazole.  
 
 
FLUCYTOSINE: 
 
This is a fluorinated pyrimidine and is fungistatic. 
 
Mechanism of action: 
 
Flucytosine is selectively taken by susceptible fungi and deaminated to  
 
fluorouracil which blocks thymidine synthesis. 
 
 
Spectrum of activity:  
 
Active against Candida,Cryptocccus and certain strains of Aspergillus,  
 
Cladosporium and Penicillium. 
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Flucytosine is often used along with Amphotericin B as a combination  
 
treatment in systemic Candidiasis and prevents development of  
 
resistance. 
 
      
Dosage: 
 
Topical: 1% solution hourly 
  
Systemic:150 mg/kg/day in 4 divided doses. 
 
Side effects: 
 
GI upset, skin rashes, bone marrow and liver toxicity. 
 
 
ITRACONAZOLE: 
 
Newer triazole with improved spectrum against filamentous fungi.It is  
 
less effective against Fusarium.It is orally effective and is available for  
 
both oral and topical use. 
 
 
Side effects include, GI upset, skin rashes, headache and reversible  
 
hepatitis. 
 
Co administration of Terfenadine and Astemizole should be avoided. 
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HYPEROSMOTIC AGENTS 
 
 
                                                           
Topical hyperosmotic agents are useful in dehydrating oedematous  
 
corneas. 
 
The clinical objective of topical osmotherapy is to increase the tonicity  
 
of tear film, thereby enhancing the rate of movement of fluid from  
 
cornea. 
 
These hyperosmotic agents are hyperosmolar to ocular fluids and when  
 
applied draw fluid from cornea to the more highly osmotic tear film  
 
which is then eliminated through normal tear flow mechanisms. 
 
 
 
Topical  Sodium chloride solution [Hypersol]: 
 
Sodium chloride is a component of all body fluids, including tears. A  
 
solution of 0.9 % is isotonic with tears. 
 
Concentrations ranging from 2% - 10% have been tried in various  
 
studies to reduce corneal oedema.5% ointment was found to be very  
 
effective in one study[Luxenburg MN, Green K. Reduction in corneal  
 
oedema with topical hypertonic agents. American Journal of  
 
ophthalmology 1971;71;847 - 853]. 
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Clinical use: 
 
Used in corneal oedema secondary to any cause, bullous keratopathy  
 
and post surgical conditions. 
 
Side effects: 
 
Stinging, burning and irritation. 
 
 
Glycerin: 
 
Used in 50 - 100% concentration. It is used for gonioscopic examination  
 
in cases of acute angle closure glaucoma, Fuch’s dystrophy and bullous  
 
keratopathy. 
 
 
Glucose: 
 
Used in 30 - 50 % concentration to treat corneal oedema. 
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RECENT ADVANCES IN MANAGEMENT 
 
 
Vasculoepithelioplasty: 
 
Indolent fungal keratitis respond poorly to conjuctival flap and  
 
therapeutic keratoplasty especially in terms of post operative visual  
 
recovery and cosmetic appearance.  
 
 
Most of these non-healing ulcers have no blood vessels around the ulcer  
 
area. Probably ischemia produced by avascularity of cornea tamper  
 
with healing mechanism.  
 
Therefore providing blood supply to the ulcer margins, thereby  
 
providing and supplementing necessary elements for healing to the  
 
ulcer bed, like mast cells, W.B.C., fibroblasts etc would help these ulcers  
 
to heal. 
 
A large vessel from the limbal area nearest to the ulcer margin is  
 
chosen. It is separated with a thin apron of conjuctiva of about 1mm on  
 
either side from the fornix towards the limbus.  
 
Conjuctiva is undermined at a depth of about 1.5mm without touching  
 
and damaging the stem cells upto 2mm inside limbus and severed with a  
 
knife.  
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It is advanced and sutured inside the ulcer margin with two 10-0  
monofilament nylon sutures. Extreme care is taken not to damage the  
limbal stem cells and the conjuctival vessel. Topical antibiotic and pad is  
applied. 
     [Nichols BD : conjuctival flaps. In Kraachmer, Mannis,Holland  
editors: cornea, vol 3 : surgery of the cornea and conjuctiva, st  
lious,1997 mosby & Sanitato J.J, Kelly C.G, Kaufmann H.E; 
     surgical management of peripheral fungal keratitis, Arch.  
    ophthmol.102:1506,1984.] 
 
Phototherapeutic Keratectomy in treating Keratomycosis:  
Using a 193-nm excimer laser, PTK can be performed to eradicate the  
 
infiltrates and facilitate antifungal therapy. 
 
After PTK, the ablated area undergoes rapid reepithelialization. PTK  
 
complications include mild corneal haze, astigmatism, and thinning of  
 
cornea. [Lippincott Williams & Wilkins, Inc. Cornea. 24(3):262-268,  
 
April 2005 Lin, Chang-Ping MD, PhD; Chang, Chi-Wu MD; Su,  
 
Chuan-Yi MD]. 
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Intracameral irrigation of Amphotericin B : 
Of late, intracameral injection of Amphotericin B is being tried in deep  
keratomycosis unresponsive to conventional anti fungals. 
This helps to reduce the exudative load in the anterior chamber as well  
as aids in targeted delivery of Amphotericin B thereby alleviating its  
potential systemic side effects.[Journal of the intraocular implant &  
refractive society of India, Jan 2005,vol.1,No.5] 
Topical application of a new antifungal agent, micafungin (MCFG), in  
the treatment of yeast-related corneal ulcers has given promising  
results. 
Topical 0.1% antifungal MCFG eye drops is applied every hour till  
epithelialization and then 5 times a day. 
[Matsumoto Y, Dogru M, Goto E, Fujishima H, Tsubota K. 
 
Department of Ophthalmology, Tokyo Dental College, Chiba, Japan ] 
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                           AIM OF THE STUDY 
 
 
Aim of the study is, 
 
                            1.To establish topical 10 % sodium chloride solution as  
 
a useful adjunct to 5% natamycin in the management of keratomycosis; 
 
 
                          2.To signify its role in quickening ulcer regression  
 
thereby alleviating additional therapy and major surgical interventions  
 
like therapeutic keratoplasty. 
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                MATERIALS AND METHODS 
 
Study was designed as a prospective randomized controlled trial on a  
 
series of 100 cases who attended Regional institute of ophthalmology  
 
and Government ophthalmic hospital with features of fungal keratitis.  
 
Patients were briefed about the study and prior consent obtained. 
 
 
Randomization: 
 
Cases were randomized into a study and control group, to experiment  
 
on one group and compare the results with the other and to weigh the  
 
outcome statistically.  
 
 
Matching: 
 
Before randomization cases were matched for ulcer size, depth of  
 
stromal involvement and presence or absence of hypopyon to achieve  
 
maximum similarity between groups and to avoid any bias creeping in. 
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Inclusion criteria 
 
    Smear and culture confirmed fungal ulcers 
 
 No Hypopyon or Hypopyon < 4mm 
 
 Depth of involvement not more than two thirds of corneal stroma 
  
 Ulcers within a week of onset 
 
 Vision 3/60 and above. 
 
 
 
 
Exclusion criteria 
 
 Fungal ulcers with bacterial  superinfection 
 
 Predisposing systemic illness 
 
 Cases who had received some treatment outside. 
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 Preparation of 10% sodium chloride solution      
 
 (hypersol): 
 
 
Usual commercially available hypertonic saline comes in 5%  
 
concentration.  
 
We thought of using hypertonic saline in a slightly higher concentration  
 
i.e. 10% for better clinical results. 
 
 
Preparation:   
 
First we steam dried Nacl powder in a hot air oven. Then 100 gms of  
 
steam dried sodium chloride was dissolved in one liter of deionised  
 
water to give a final concentration of 10%. 
 
Resultant solution was autoclaved and the final solution dispensed in  
 
autoclaved and labeled 5 ml bottles for patient use. 
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Course of the study: 
 
For all cases we first recorded an exhaustive clinical history and then  
 
patients were subjected to slit lamp biomicroscopy . 
 
 
                          AGE DISTRIBUTION 
 
Age  No. of cases 
0 - 10 9 
11 - 20 9 
21 - 30 8 
31 - 40 12 
41 - 50 17 
51 - 60 18 
61 - 70 15 
71 - 80 3 
 
                           
 
                          SEX DISTRIBUTION 
 
Age range Male Female 
0 - 10 3 6 
11 - 20 8 1 
21 - 30 5 3 
31 - 40 9 3 
41 - 50 16 1 
51 - 60 13 5 
61 - 70 11 4 
71 - 80 2 1 
Total 67 33 
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Size, shape and depth of stromal involvement of the ulcer were recorded  
 
in the case  sheet. Presence or absence satellite lesions, immune ring,  
 
stromal abscess,  endothelial plaque, hypopyon and anterior chamber  
 
reaction were also recorded and documented.  
 
 
Cases with high clinical suspicion of fungal keratitis were then subjected  
 
to clinical investigations to confirm the fungal etiology. 
 
 
We used 10% KOH mount to identify the fungal elements and  
 
Sabouraud’s agar was inoculated simultaneously and maintained at  
 
room temperature for species identification. Gram’s smear was set to  
 
exclude bacterial superinfection in all the cases. 
 
 
Cases were then randomly categorized as either Group A  [study group]  
 
or Group B [control group]. 
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Treatment protocol and methodology: 
 
                                     
Group A received topical 10% sodium chloride along with 5%  
 
Natamycin,while Group B received Natamycin alone and served as  
 
control. 
 
 
Dosage schedule: 
                                            
Group A received 10% Sodium chloride solution one drop six times per  
 
day for 6 weeks and 5% Natamycin one drop hourly for the first week,  
 
every two hours for two weeks and then six times a day till the end of  
 
the study. 
 
 
Group B received only 5% Natamycin one drop hourly for the first  
 
week, every two hours for two weeks and then six times a day till the  
 
end of the study. 
 
 
Both groups received 1% atropine eye drops one drop thrice daily. 
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FOLLOW UP 
 
 
All cases were followed biweekly for six weeks using slit lamp  
 
biomicroscopy. Signs of regression and progression were carefully  
 
looked for and recorded. 
 
 
REGRESSION: 
 
                             Regression was defined as 
 
 
                                             Resolution of infiltrates 
                                              
                                             Hypopyon clearance 
                                              
                                                  Epithelial regrowth 
                                              
                                             Resolution of stromal oedema 
 
  
PROGRESSION: 
 
                             Progression was defined as  
                                     
                                             Worsening symptoms  
 
                                             Advancing infiltrates 
 
                                             Increase in stromal oedema 
 
                                             Formation of stromal abscess 
 
                                             Descematocoele formation 
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OUTCOME 
 
 
All the 100 cases were followed for a period of six weeks biweekly. 
 
The main outcome parameters that were looked for include, signs of  
 
regression as already mentioned and mean time taken for complete  
 
regression. 
 
 
Number of cases necessitating additional therapies in the form of  
 
anterior chamber wash with Amphotericin B, treatment with other  
 
antifungals like Fluconazole,0.15% Amphotericin B,in either group  
 
were also recorded. 
 
     
Surgical intervention like therapeutic keratoplasty in each group was  
 
also taken into consideration. 
 
In group A [n = 50], 42 cases started showing signs of regression at end 
of 2 weeks with complete resolution of infiltrates at a mean period of 3.4 
weeks. 
 
 
Rest of the 8 cases required some additional intervention. Out of these 2  
 
cases underwent Amphotericin B anterior chamber wash.  
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Additional topical antifungals were used in 3 cases and 3 patients  
 
necessitated therapeutic keratoplasty.  
 
 
In group B [n=50], 28 cases started showing signs of regression at end of  
 
4 weeks with complete resolution of infiltrates at a mean period of 4.6  
 
weeks. 
 
Rest of the 22 cases required some additional intervention. Out of these 6 
cases  underwent  Amphoter ic in  B an te r io r  chamber  wash . 
Topical antifungals (topical fluconazole) were used in 8 cases and 8  
 
patients necessitated therapeutic keratoplasty. 
 
 
Among the culture isolates, Aspergillus fumigatus predominated  
 
followed by Fusarium. 
 
       
CULTURE ISOLATE 
 
Fungal species No. of cases Percentage 
Aspergillus fumigatus 34 34% 
Fusarium  29 29% 
Aspergillus flavus 19 19% 
Aspergillus niger 18 18% 
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                                    OUTCOME- GROUP A (n=50) 
 
 
             
  
No. of cases 
 
Percentage 
Complete regression 42 84% 
Therapeutic keratoplasty 3 6% 
AC Wash 2 4% 
Additional antifungal 3 6% 
                        
 
 
 
                                    OUTCOME - GROUP B (n=50) 
 
 
             
  
No. of cases 
 
Percentage 
Complete regression 28 56% 
Therapeutic keratoplasty 8 16% 
AC Wash 6 12% 
Additional antifungal 8 16% 
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STATISTICAL ANALYSIS 
  
Results though apparent were statistically analyzed to support the  
 
clinical findings. 
 
We used the chi-square test (ﻼ 2 ) to test the significance of difference  
 
between the two groups.                                       
 
Applying the chi-square test, 
         
 
    ﻼ 2      = Σ (O- E)2 
 
        E 
 
Where O is the observed value  
        
             E is the expected value 
 
Here expected value = 70 x 50     
           100 
 
                                =    35 
 
ﻼ 2  =   (42-35)2   + (28-35)2 + (8-15)2 +   (22-15)2 
          35       35                15              15 
 
     = 49  49  49  49 
  +  +  + 
   35  35  15  15 
 
= 98  98   
  +  = 2.8+ 6.53  
35 15 
 
  ﻼ 2   = 9.33  
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Allowing a degree of freedom of 1, from the probability table, expected 
chi-square (ﻼ 2 ) value is 3.84 which is very well below our value. 
 
Applying the null hypothesis, we get a significant P value of > 0.05,  
 
statistically signifying our clinical results.
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DISCUSSION 
 
 
In group A, 84% of cases showed complete regression at a mean period  
 
of 3.4 weeks, 4% of cases required Amphotericin B anterior chamber  
 
wash, 6% required additional topical antifungals and another 6%  
 
necessitated therapeutic keratoplasty.  
 
 
In group B, 56% of cases showed complete regression at a mean period  
 
of 4.6 weeks, 12% of cases required Amphotericin B anterior chamber  
 
wash, 16% required additional topical antifungals and another 16%  
 
necessitated therapeutic keratoplasty.  
 
 
 
 
 
 
 
Group 
 
Complete regression (in weeks) 
 
A 
 
3.4 
 
B 
 
4.6 
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Used in such high concentrations, topical 10% sodium chloride solution  
causes resolution of stromal oedema and better penetration of  
antifungals into the organisms. 
We also demonstrated that used in such high concentrations, it retards  
 
growth of bacteria in cultures. 
 
Probably this effect may be therapeutically important in preventing  
 
superadded bacterial infections in fungal ulcers. 
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CONCLUSION 
 
 
This comparative study clearly demonstrates, that the study group  
 
receiving 10% sodium chloride solution heals faster, rate of progression  
 
is slowed down and complications are obviously less in comparison to  
 
the group receiving 5% Natamycin alone. 
 
 
Also the number of therapeutic keratoplasties is significantly less  
 
compared to the control group. 
 
Therapeutic efficacy of 10% sodium chloride solution is attributed to its  
 
anti oedema property. 
 
 
Hence topical 10% sodium chloride solution can be used along with  
 
5% Natamycin, as a cost effective adjunct in the management of fungal  
 
keratitis. 
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PROFORMA 
 
 
Name:                                                  Date of study:                                  
 
Address:                                                       
 
Age:                                                     Date of Admission: 
 
Sex:                                                     Date of Discharge: 
 
Occupation: 
 
OP No:                                                 MRD No:                                
 
Complaints:  Pain, redness, watering, photophobia .       RE/LE               
 
Duration:  
 
History of present illness: 
 
History of injury with stick/Thorn/Fall of dust/others 
 
Past history: H/O T.B/leprosy/Diabetes/Syphilis 
 
Family History: 
 
General Examination: 
 
OCULAR EXAMINATION:                            RE                                 LE  
 
Visual Acuity: 
 
Lids & Adnexa: 
 
Conjunctiva: 
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Cornea: 
 
          Ulcer Size/Shape: 
 
                    Site: Central/Marginal 
 
                    Hypopyon Size: 
 
                    Satellite Lesion:     
 
                    Depth of involvement: 
 
Anterior Chamber: 
 
Iris: 
 
Pupil: 
 
Lens: 
 
Corneal sensation: 
 
Fluorescein staining: 
 
INVESTIGATIONS: 
 
Duct: 
 
Conjunctival Smear: 
 
Corneal smear[Gram’s/Giemsa] 
 
KOH Prep: 
 
Fungal culture 
 
Urine-Albumin/Sugar/RBS: 
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                                  THERAPEUTIC TRIAL      
 
                  
             STUDY GROUP                                      CONTROL GROUP                         
     
                       [A]                                                                 [B] 
 
           [Topical 10% hypersol                             [  Topical 5%  Natamycin      
         
                         &                                                               alone]                                            
      
         Topical 5% Natamycin]  
                                                                                                                                       
     
                                                     FOLLOW UP 
 
Week 1 2 3 4 5 6 
Ulcer Size:       
Hypopyon       
Stromal 
oedema 
      
Infiltrates        
  
 
REMARKS: 
 
Amphotericin AC wash: 
 
Additional antifungal (if any): 
 
Therapeutic keratoplasty: 
                                                         
 
 
                                                            
  
MASTER CHART 
 
SN NAME  A
G 
S
X 
      IP.No  I
N 
U
S 
UD S
L 
H
Y 
KO
H 
FC G
P 
TR 
 
TKP AW OA 
1 kanniga 45 F 395936 + 5 1/2 + + SH FU A _   + 
2 Suresh 19 M 396396 + 3 2/3 _ + SH AFL B +    
3 Samuel 15 M 396509 + 2 2/3 _ + SH AFL B +    
4 Kumari 22 F 396340 + 4 2/3 _ + SH AN B _ +   
5 Vikram 14 M 395752 + 3 2/3 _ + SH AFL B +    
6 Pencillamma 40 F 396471 + 2 1/2 + + SH FU B _  +  
7 Lakshmi 55 F 396166 + 3 2/3 _ _ SH AFL B _ +   
8 Jamal 65 M 396587 + 3 1/2 _ + SH AFU B _  +  
9 Rajammal 50 F 396299 + 2 2/3 _ _ SH FU B +    
10 Rasammal 75 F 396649 + 4 1/2 + + SH AFL B _   + 
11 Muthalamma 65 F 396480 + 3 2/3 _ + SH AN A +    
12 Joseph 11 M 396359 + 4 2/3 _ + SH FU A _ +   
13 Thirurani 58 F 394550 + 2 2/3 + + SH AFU A +    
14 Pushparani 32 F 396722 + 3 1/2 _ _ SH AFU A _   + 
15 Ramasamy 50 M 396541 + 3 2/3 + _ SH AN A +    
16 Natarajan 47 M 395465 + 2 1/2 _ _ SH FU A +    
17 Kasthuri 45 F 396386 + 3 2/3 _ + SH AFU A +    
18 Maran  51 M 395231 + 5 1/2 + _ SH AFU A +    
19 Pitchandi 40 M 396669 + 2 2/3 + _ SH FU A +    
20 Snekha 4 F 396529 _ 2 1/2 _ _ SH AFU A +    
21 Desigan 45 M 395893 + 3 1/2 _ _ SH AFU A +    
22 Yasodha 55 F 395984 + 4 2/3 + _ SH AN A +    
23 Mahesh 12 M 396748 + 3 1/2 _ + SH FU B +    
24 Velu 62 M 396762 + 3 1/2 + + SH AFU B +    
25 Palani 37 M 396725 + 3 2/3 _ _ SH AFU B _ +   
26 Natarajan 47 M 396803 + 2 2/3 _ _ SH AN B +    
27 Ramanathan 68 M 396775 + 3 1/2 _ + SH FU B +    
28 Muniammal 30 F 396892 + 4 1/2 _ + SH FU B +    
29 Muthu 46 M 396714 + 2 1/2 _ + SH AFU B +    
30 Venkaiah 65 M 396868 + 3 2/3 + + SH AFU B +    
31 Devarani 50 F 396553 + 3 2/3 _ + SH AFL A +    
32 Ramadoss 47 M 396955 + 2 2/3 _ _ SH FU A +    
33 Gajendran 45 M 397162 + 3 1/2 _ _ SH AFU A _ +   
34 Lingammal 45 F 397117 + 2 1/2 + _ SH FU A +    
35 Sandhya 43 F 396769 + 3 2/3 _ _ SH AN A +    
36 Padmavathy 45 F 397074 + 2 2/3 _ _ SH AFU B +    
37 Loganathan 57 M 396923 + 3 1/2 _ + SH FU B +    
38 Munusamy 50 M 397216 + 5 1/2 _ + SH AN B +    
39 Muthu 27 M 397217 + 2 2/3 _ + SH AFU B +    
40 Manikandan 18 M 397073 + 4 2/3 _ _ SH AN B +    
41 Murthy 25 M 397180 + 3 2/3 + + SH FU A +    
42 Ayisha 53 F 397222 + 2 2/3 _ _ SH AFU A +    
43 Munusamy 21 M 397201 + 3 2/3 _ + SH AN A +    
44 Ramasamy 67 M 396961 + 4 1/2 _ _ SH AFU A +    
45 Shesadri 25 M 397156 + 2 1/2 _ + SH FU A +    
46 Gabriel 62 M 396799 + 3 1/2 _ _ SH AFU A +    
47 Balaji 18 M 396948 + 2 1/2 _ + SH AFL A +    
48 Chellavelu 55 M 395193 + 3 2/3 + + SH AFL A +    
49 Palpandian 58 M 396717 + 2 2/3 _ + SH FU A +    
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TKP AW OA 
50 Palani 37 M 396930 + 2 1/2 _ + SH FU B _  +  
51 Dhandapani 51 M 397115 + 3 2/3 _ + SH AFU B _ +   
52 Duraisamy 50 M 396711 + 3 2/3 _ + SH AN B _  +  
53 Raju 56 M 396946 + 2 2/3 + _ SH AFU B _ +   
54 Visalatchi 55 F 396996 + 2 1/2 _ _ SH AFU B +    
55 Rosaiah 45 M 396814 + 5 1/2 _ _ SH AFU B _ +   
56 Pitchandi 40 M 396794 + 3 2/3 + _ SH AFL B +    
57 Arumugam 58 M 396903 + 2 1/2 + + SH AFL B _   + 
58 Munusamy 65 M 396852 + 2 2/3 _ _ SH FU B _ +   
59 Anjammal 45 F 397099 + 3 1/2 _ + SH FU B _   + 
60 Mutulashmi 60 F 397081 + 3 2/3 + _ SH FU B +    
61 Jeyasri 1 F 397469 + 3 2/3 _ + SH AFL B _  +  
62 Karupamma 70 F 397219 + 3 1/2 _ + SH AN B +    
63 Rubavalli 15 F 397046 + 2 1/2 _ + SH AFL B _   + 
64 Kasinathan 46 M 397401 + 2 1/2 _ + SH AFL A +    
65 Kirthiraj 50 M 397366 + 2 2/3 + _ SH AN B +    
66 Shiva 10 M 397187 + 3 2/3 + _ SH AFU A +    
67 Shanmugam 33 M 397566 + 2 1/2 _ _ SH AFU A _  +  
68 Kaliammal 68 F 397237 + 3 1/2 _ + SH AFU A _ +   
69 Akila 9 F 397620 + 2 2/3 _ + SH FU A +    
70 Anandi 9 F 397271 + 4 1/2 _ + SH AFL A +    
71 Thanganadar 65 M 397742 + 2 2/3 _ + SH AFU B +    
72 Saravanan 14 M 397244 + 3 2/3 + + SH AFL A +    
73 Mari 80 F 397323 + 3 2/3 _ + SH AFU B +    
74 Vijayan 23 M 397390 + 2 2/3 _ + SH AN B +    
75 Rathinam 66 M 397606 + 3 2/3 + + SH FU A +    
76 Sivakumar 20 M 397320 + 2 1/2 _ _ AF AFU B +    
77 Malayan 37 M 397269 + 4 1/2 _ + SH AN B +    
78 Sundaram 47 M 397400 + 2 1/2 _ _ SH AFL A +    
79 Arasu  36 M 397395 + 4 1/2 _ + SH FU B +    
80 Ganapathi 60 M 397059 + 2 1/2 _ + SH AFU B _  +  
81 Rajendran 45 M 397438 + 4 1/2 _ + SH AFU A +    
82 Rathinam 66 M 397347 + 3 2/3 _ + SH AFU B +    
83 Gabriel 62 M 397391 + 4 2/3 + + SH FU A +    
84 Rajkumar 3 M 397480 + 2 2/3 _ + SH FU B _   + 
85 Rathinam 65 M 397084 + 2 2/3 _ + SH AFL A _  +  
86 Deepika 2 F 396931 + 3 2/3 _ _ SH AFL A _   + 
87 Nagarajan 40 M 396921 + 2 1/2 _ + SH AN A +    
88 Durga 7 F 397421 + 3 1/2 + _ SH FU B _   + 
89 Muthulakmi 50 F 397417 + 2 1/2 _ + SH FU A +    
90 Mohamed 38 M 396815 + 2 2/3 _ + SH AFU B _   + 
91 Kannan 57 M 397718 + 3 2/3 + + SH AFU A +    
92 Amirtammal 63 F 397578 + 4 1/2 _ + SH AFL A +    
93 Sanyasi 60 M 397627 + 3 1/2 _ + SH FU A +    
94 Chinaammal 40 F 397739 + 3 2/3 + _ SH AFU A +    
95 Malliga 28 F 396733 + 2 1/2 _ _ SH AN A +    
96 Elumalai 57 M 397798 + 2 2/3 _ _ SH AN A +    
97 krishnan 45 M 397443 + 2 1/2 _ + SH FU A +    
98 Muthu 47 M 394321 + 4 1/2 _ + SH AFU B _ +   
99 Munusamy 75 M 397629 + 2 2/3 _ + SH AN A +    
100 Ramasamy 50 M 397883 + 2 2/3 _ _ SH FU B _   + 
                             
  
KEY TO MASTER CHART 
 
 
SN Serial number 
 
AG Age 
 
SX Sex 
 
M Male 
 
F Female 
 
IP. No Inpatient number 
 
IN H/O Injury 
 
US Ulcer size (in mm) 
 
UD Ulcer depth (Extent of stromal involvement) 
                                                                          
SL Satellite lesions 
 
HY Hypopyon                                                
 
FC Fungal culture 
 
GP Group 
 
TR Total regression 
 
TKP Therapeutic keratoplasty 
 
AW Amphotericin AC wash 
 
OA Other antifungal (Fluconazole) 
 
SH Septate Hyphae 
                                               
FU Fusarium 
 
AFL Aspergillus flavus 
  
 
AN Aspergillus niger 
 
AFU Aspergillus fumigatus 
 
A Group A 
 
B Group B 
 
 
 
 
 
                                           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
LIST OF SURGERIES 
 
 
 
S.NO 
 
 
NAME 
 
 
AGE 
 
 
SEX 
 
 
IP.NO 
 
 
DIAGNOSIS 
 
 
SURGERY 
 
1 
 
Kumari 
 
22 
 
F 
 
396340 
  Resistant 
  Fungal keratitis 
 
TKP 
 
2 
 
Lakshmi 
 
55 
 
F 
 
396166 
  Resistant 
  Fungal keratitis 
 
TKP 
 
3 
 
Joseph 
 
11 
 
M 
 
396359 
  Resistant 
  Fungal keratitis 
 
TKP 
 
4 
 
Palani 
 
37 
 
M 
 
396725 
  Resistant 
  Fungal keratitis 
 
TKP 
 
5 
 
Gajendran 
 
45 
 
M 
 
397162 
  Resistant  
  Fungal keratitis 
 
TKP 
 
6 
 
Dhandapani 
 
51 
 
M 
 
397115 
  Resistant 
  Fungal keratitis 
 
TKP 
 
7 
 
Raju 
 
56 
 
M 
 
396946 
  Resistant 
  Fungal keratitis 
 
TKP 
 
8 
 
Rosaiah 
 
45 
 
M 
 
396814 
  Resistant 
  Fungal keratitis 
 
TKP 
 
9 
 
Munusamy 
 
65 
 
M 
 
396852 
  Resistant 
  Fungal keratitis 
 
TKP 
 
10 
 
Kaliammal 
 
68 
 
F 
 
397237 
  Resistant 
  Fungal keratitis 
 
TKP 
 
11 
 
Muthu 
 
47 
 
M 
 
394321 
  Resistant 
  Fungal keratitis 
 
TKP 
 
 
TKP - Therapeutic keratoplasty 
BEFORE TREATMENT 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AFTER 4 WEEKS OF  TREATMENT WITH 10% HYPERSOL 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A LOCALISED DEPRESSION OF THE SUPEROTEMPORAL PARACENTRAL 
CORNEA  IN KERATOMYCOSIS 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CORNEAL TOPOGRAPHY SHOWING HEALED KERATITIS CAUSING A 
LOCALISED DEPRESSION IN THE SUPERIOR PARACENTRAL CORNEA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CLASSICAL FUNGAL ULCER WITH FEATHERY MARGINS  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KOH MOUNT SHOWING SEPTATE HYPHAE 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HPE SHOWING FUNGAL HYPHAE IN ANTERIOR STROMA 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LACTOPHENOL COTTON BLUE STAINING SHOWING BOAT  
SHAPED SPORES OF FUSARIUM 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HPE - FUNGAL HYPHAE IN SUPERFICIAL STROMA 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PAS STAINING SHOWING MID STROMAL HYPHAE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BEFORE TREATMENT 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AFTER 4 WEEKS OF TREATMENT WITH 10% HYPERSOL 
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OUTCOME  - GROUP A
4%
84%
6%
6%
Complete Regression Therapeutic Keratoplasty AC wash Additional Antifungals
 
 
  
O U T C O M E   -  G R O U P  B
1 2 %
5 6 %
1 6 %
1 6 %
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